|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 帕博利珠单抗单用或与放疗联用治疗转移性非小细胞肺癌:两个随机试验的汇总分析显示文摘背景放疗可以提高整个机体对免疫治疗的应答。在Ⅱ期PEMBRO-RT研究和Ⅰ/Ⅱ期MDACC研究中,患有转移性非小细胞肺癌(NSCLC)的患者被随机分配入组,接受免疫治疗(帕博利珠单抗)+放疗联合疗法,或免疫治疗单一疗法。当上述2个研究单独分析时,联合疗法组显示出潜在获益。由于每个研究的样本量较小,缓解率和结局并未显示出统计学意义,然而却有显著的临床获益。因此,本研究进行汇总分析,来判断放疗是否会改善转移性NSCLC患者的免疫治疗应答。方法PEMBRO-RT和MDACC研究纳入标准:患者年龄≥18岁,患有转移性NSCLC,且有≥1处未经放疗照射的病灶,以便进行射野外应答监测。PEMBRO-RT研究纳入曾接受过化疗患者,MDACC研究纳入曾接受过治疗或新诊断患者。2个研究中的患者均未接受过免疫治疗。在PEMBRO-RT研究中患者被等比例随机分配入组,并根据吸烟状态进行分层(分为<10年组和≥10年组)。MDACC研究的患者根据放疗计划可行性被等比例随机分配入2个受试组。由于联合治疗组的干预本质,每个研究中的放疗均不适用盲法。在2个研究中,不论是否进行放疗,均静脉滴入帕博利珠单抗(每3周200 mg)。在PEMBRO-RT研究中,在放疗(24 Gy 3次分割照射)结束后1周给予第1剂帕博利珠单抗。在MDACC研究中,在第1次放疗(50 Gy 4次分割照射或45 Gy 15次分割照射)同时给予帕博利珠单抗。仅检测未经照射病灶的应答。本研究的终点为最佳射野外(远隔)应答率(ARR)、最佳射野外疾病控制率(ACR)、12周时ARR、12周时ACR、无进展生存期(PFS)和总生存期(OS)。2个研究的意向治疗(ITT)人群均纳入分析。PEMBRO-RT研究(NCT02492568)和MDACC研究(NCT02444741)均在ClinicalTrials.gov上注册。发现纳入148例患者,76例接受帕博利珠单抗治疗,72例接受帕博利珠单抗+放疗治疗。所有患者随访时间中位数为33个月[四分位距(IQR):32.4~33.6]。148例患者中124例(84%)组织学特征为非鳞癌,111例(75%)患者曾经接受过化疗。组间没有基线特征差异,包括PD-L1表达状态和转移灶体积。最常见的照射部位为肺转移灶(39%,28/72)、胸腔内淋巴结(21%,15/72)和非原发灶(17%,12/72)。帕博利珠单抗组和联合治疗组的最佳ARR分别为19.7%(15/76)和41.7%(30/72),OR=2.96,95%CI:1.42~6.20,P=0.0039;最佳ACR分别为43.4%(33/76)和65.3%(47/72),OR=2.51,95%CI:1.28~4.91,P=0.0071;PFS中位数分别为4.4(IQR:2.9~5.9)和9.0个月(IQR:6.8~11.2),HR=0.67,95%CI:0.45~0.99,P=0.045;OS中位数分别为8.7(IQR:6.4~11.0)和19.2个月(IQR:14.6~23.8),OR=0.67,95%CI:0.54~0.84,P=0.0004。在汇总分析中没有发现新的安全问题。解读帕博利珠单抗免疫疗法+放疗显著提高转移性NSCLC患者的应答和改善治疗结局。这些结果需要在三期临床试验中进行验证。 | 陈大卫(翻译) 于金明(校对) Willemijn S M E Theelen Vivek Verma Brian P Hobbs Heike M U Peulen Joachim G J V Aerts Idris Bahce Anna Larissa N Niemeijer Joe Y Chang Patricia M de Groot Quynh-Nhu Nguyen Nathan I Comeaux George R Simon Ferdinandos Skoulidis Steven H Lin Kewen He Roshal Patel John Heymach Paul Baas James W Welsh | 2021 | 中华肿瘤防治杂志2021，28，24： | 49 |
| 2 | KOH activated carbon derived from biomass-banana fibers as an efficient negative electrode in high performance asymmetric supercapacitor显示文摘Here we demonstrate the fabrication, electrochemical performance and application of an asymmetric supercapacitor(AS) device constructed with β–Ni(OH)_2/MWCNTs as positive electrode and KOH activated honeycomb-like porous carbon(K-PC) derived from banana fibers as negative electrode. Initially,the electrochemical performance of hydrothermally synthesized β–Ni(OH)_2/MWCNTs nanocomposite and K-PC was studied in a three-electrode system using 1 M KOH. These materials exhibited a specific capacitance(Cs) of 1327 F/g and 324 F/g respectively at a scan rate of 10 m V/s. Further, the AS device i.e.,β–Ni(OH)_2/MWCNTs//K-PC in 1 M KOH solution, demonstrated a Cs of 156 F/g at scan rate of 10 m V/s in a broad cell voltage of 0–2.2 V. The device demonstrated a good rate capability by maintaining a Cs of 59 F/g even at high current density(25 A/g). The device also offered high energy density of 63 Wh/kg with maximum power density of 5.2 kW/kg. The AS device exhibited excellent cycle life with 100% capacitance retention at 5000 th cycle at a high current density of 25 A/g. Two AS devices connected in series were employed for powering a pair of LEDs of different colors and also a mini fan. | ChaitraK Vinny R T Sivaraman P Narendra Reddy Chunyan Hu Krishna Venkatesh Vivek C S Nagaraju N Kathyayini N | 2017 | Journal of Energy Chemistry2017，26，1： | 4 |
| 3 | Kidney exchange transplantation current status, an update and future perspectives显示文摘Kidney exchange transplantation is well established modality to increase living donor kidney transplantation. Reasons for joining kidney exchange programs are ABO blood group incompatibility, immunological inco-mpatibility(positive cross match or donor specific antibody), human leukocyte antigen(HLA) incompa-tibility(poor HLA matching), chronological incompa-tibility and financial incompatibility. Kidney exchange transplantation has evolved from the traditional si-multaneous anonymous 2-way kidney exchange to more complex ways such as 3-way exchange, 4-way exchange, n -way exchange,compatible pair, non-simult-aneous kidney exchange,non-simultaneous extended altruistic donor, never ending altruistic donor, kidney exchange combined with desensitization, kidney ex-change combined with ABO incompatible kidney tr-ansplantation, acceptable mismatch transplant, use of A2 donor to O patients, living donor-deceased donor list exchange, domino chain, non-anonymous kidney exchange, single center, multicenter, regional, National, International and Global kidney exchange. Here we discuss recent advances in kidney exchanges such as International kidney exchange transplantation in a gl-obal environment, three categories of advanced dona-tion program, deceased donors as a source of chain initiating kidneys, donor renege myth or reality, pros and cons of anonymity in developed world and(non-) anonymity in developing world, pros and cons of donor travel vs kidney transport, algorithm for management of incompatible donor-recipient pairs and pros and cons of Global kidney exchange. The participating transplant teams and donor-recipient pairs should make the decision by consensus about kidney donor travel vskidney transport and anonymity vs non-anonymity in allocation as per local resources and logistics. Future of organ transplantation in resource-limited setting will be liver vs kidney exchange, a legitimate hope or utopia? | Vivek B Kute Narayan Prasad Pankaj R Shah Pranjal R Modi | 2018 | World Journal of Transplantation2018，8，3： | 2 |
| 4 | Learning two-phase microstructure evolution using neural operators and autoencoder architectures显示文摘Phase-field modeling is an effective but computationally expensive method for capturing the mesoscale morphological and microstructure evolution in materials.Hence,fast and generalizable surrogate models are needed to alleviate the cost of computationally taxing processes such as in optimization and design of materials.The intrinsic discontinuous nature of the physical phenomena incurred by the presence of sharp phase boundaries makes the training of the surrogate model cumbersome.We develop a framework that integrates a convolutional autoencoder architecture with a deep neural operator(DeepONet)to learn the dynamic evolution of a two-phase mixture and accelerate time-to-solution in predicting the microstructure evolution.We utilize the convolutional autoencoder to provide a compact representation of the microstructure data in a low-dimensional latent space.After DeepONet is trained in the latent space,it can be used to replace the high-fidelity phase-field numerical solver in interpolation tasks or to accelerate the numerical solver in extrapolation tasks. | Vivek Oommen Khemraj Shukla Somdatta Goswami Rémi Dingreville George Em Karniadakis | 2022 | npj Computational Materials2022，，1： | 2 |
| 5 | Design Guidelines for Wireless SensorNetworks:Communication,Clustering and Aggregation显示文摘 | Vivek M Catherine R | 2004 | AdHoc Networks2004，2，1： | 1 |
| 6 | Quantification and comparison of telovelar and transvermian approaches to the fourth ventricle 显示文摘 | Vivek R Deshmukh E Gadelha F | 2006 | Neurosurgery2006，58，2： | 1 |
| 7 | Coating polymers for colon specific drug delivery: Acomparativeinvitroevaluation显示文摘 | Vivek R S Rachna K | 2003 | ActaPharmaceutical2003，53，： | 1 |
| 8 | ' Eye is a window to thepulse' : bilateral ocular ischaemic syndrome as a presentingmanifestation of Takayasu arteritis显示文摘 | Shailaja S Vivek G Shetty R | 2013 | BMJ Case Rep2013，29，： | 1 |
| 9 | A counterexample in congestion control of wireless networks显示文摘 | Vivek Raghanathan Kumar P R | 2007 | Elsevier Science Publishers BV2007，64，5： | 1 |
| 10 | Bone marrow-derived lin-c-kit+Sca-1+ stem cells do not contribute to vasculogenesis in lewis lung carcinoma显示文摘 | Vivek R Shinde Patil Erik B | 2005 | Neoplasia2005，7，3： | 1 |
| 11 | Managerial Ownership and Firm Valuation:Evidence from Japanese Firms显示文摘 | Carl R Chen Weiyu Guo Vivek Mande | 2003 | Pacific-Basin Finance Journal2003，11，3： | 1 |
| 12 | Wardrop routing in wireless networks显示文摘 | Vivek R Kumar P R | 2009 | IEEE Trans on Mobile Computing2009，8，5： | 1 |
| 13 | Design guidelines for wireless sensor networks:communication, clustering and aggregation显示文摘 | Vivek M Catherine R | 2004 | Ad Hoc Networks2004，2，1： | 1 |
| 14 | Cardiac cell transplantation:closer to bedside显示文摘 | Osman O Al-radi M Vivek R | 2003 | Ann Thorac Surg2003，75，2： | 1 |
| 15 | Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer显示文摘 | SAHDEO Prasad KANNOKARN Phromnoi VIVEK R Yadav | | 0，，11： | 1 |
| 16 | An Empirical Examination Of VolatiliW Spillover Between the Indian and Us Swap Markets显示文摘 | Vivek B Malhotra D K Philip R Rahul S | 2012 | Intemational Journal of Emerging Markets2012，7，3： | 1 |
| 17 | Genetic analysis and molecular phylogeny of simian T-cell lymphotropic virus type Ⅰ: evidence for independence virus evolution in Asia and Africa 显示文摘 | Ki-Joon S Vivek R Naruya S | 1994 | Virology1994，199，： | 1 |
| 18 | Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion 显示文摘 | Azad R Vivek K Sharma Y | 2012 | Indian J Ophthalmol2012，60，4： | 1 |
| 19 | Comparative studies on flow control in rectangular S-duct diffuser using submerged-vortex generators显示文摘 | Akshoy R P Pritan S R Vivek K P | 2013 | Aerospace Science and Technology2013，28，1： | 1 |
| 20 | Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter显示文摘 | Sangeeta K C Sandip K M Vivek M R | 2003 | J Biol Chem2003，278，19： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员